Your Source for BioScience Venture Capital Data
  • SEARCH THE OnBioVC DATABASE:

  • OnBioVC NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • Photobucket

  • FDA Registered Contract Manufacturer

Millions of Technologies and Inventors from Hundreds of Universities and Research Institutes Now Accessible in a Single Search Boulder, CO April 22, 2013 – Collective IP, Inc., the global leader in innovation intelligence, announced today the launch of CollectiveIP.com, a new approach to search for technology transfer asset identification. The Collective IP search engine gives [...]

NanoBio (Ann Arbor, MI), a clinical-stage biotechnology company focused on anti-infective intranasal & intramuscular vaccines for influenza, closed an $11M Series C financing. Participants include Perseus and Venture Investors.

Rib-X Pharmaceuticals (New Haven, CT), a clinical-stage pharmaceutical company developing next-generation antibiotics, closed an $18.7M Series B financing. Participants include Vatera Healthcare Partners, Warburg Pincus, ABS Ventures and Vox Equity Partners.

CardiAQ Technologies (Irvine, CA), a developmental-stage medical device company focused on percutaneous mitral heart valve replacement, closed a $37.3M Series B financing. Participants include OrbiMed, Versant Ventures, Advent Life Sciences and Broadview Advisors.

GlySure (United Kingdom), a clinical-stage medical device company focused on continuous blood glucose monitoring, closed a $13.6M Series C financing. Participants include Amadeus Capital Partners, Chester Investments, Delta Partners and Morningside Ventures.

TriReme Medical (Pleasanton, CA), a commercial-stage medical device company focused on percutaneous devices for the treatment of coronary and peripheral arterial disease, closed an $18M Series E financing. Participants include Luminor Capital.

Are you attending the 2013 BIO International Convention and have Technology Transfer, Business Development and/or In-/Out-Licensing on your mind? Then come take a break from the BIO convention floor, rest your feet, relax and enjoy some cocktails and delicious snacks and deserts at Shaw’s, a jazzy, sophisticated, seafood restaurant and carefree, lively oyster bar. DIRECTIONS:Take [...]

TransMedics (Andover, MA) a commercial-stage medical device company focused on organ preservation technologies for transplants, closed a $36M Series E financing. Participants include Abrams Capital, Flagship Ventures, Hercules Technology Growth Capital and Kleiner Perkins Caufield & Byers.

Endosense (Switzerland), a commercial-stage medical device company focused on catheter ablation for cardiac arrhythmias, closed a $40.3M Series C financing. Participants included NGN Capital, Edmond de Rothschild Investment Partners, NeoMed Management, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.

TxCell (France), a clinical-stage biotechnology developing cell-based immunotherapies for chronic inflammatory and neurological diseases, closed a $15.9M Series C financing. Participants include CDC Entreprises, Auriga Partners and Seventure Partners. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets Receive Collective IP [...]

Rhythm Pharmaceuticals (Boston, MA), a clinical-stage biotechnology company focused on peptide therapeutics for metabolic disorders, closed an $8M Series B financings, bringing the total round to $33M. Participants include Pfizer Ventures, MPM Capital, New Enterprise Associates, Third Rock Ventures and Ipsen Ventures. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive [...]

MabVax Therapeutics (San Diego, CA), a clinical-stage biotechnology company focused on cancer immunotherapies, closed a $5.3M Series B financing. Participants include Numoda Capital Innovations, Burrill & Co. and RTP Venture Fund. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets Receive [...]

Applied Genetic Technologies (Gainesville, FL), a clinical-stage biotechnology company focused on respiratory and retinal diseases, closed a $37.5M Series B financing. Participants include Alta Partners, S.R. One, Osage University Partners, InterWest Partners, Intersouth Partners and MedImmune Ventures. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds [...]

« Previous Page« Previous Entries  Next Entries »Next Page »

to top of page...